IL1B and diabetic kidney disease: Naringenin attenuated DKD through its anti‐inflammatory and antifibrotic activities by decreasing the expression of IL‐1β, IL‐6, fibronectin, type IV collagen, and TGF‐β1 (Salehi et al. 2019).